(Q46701148)

English

Differential association between statin exposure and elevated levels of creatine kinase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

Differential association between statin exposure and elevated levels of creatine kinase (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

author name string

James Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

Rita L Hui

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

Eleanor Levin

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

language of work or name

0 references

publication date

13 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

39

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

1611-1616

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Withdrawal of cerivastatin from the world market

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Statin-associated myopathy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

FDA adverse event reports on statin-associated rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Statin-associated myopathy with normal creatine kinase levels

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

HMG-CoA reductase inhibitors and myotoxicity

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Cerivastatin and reports of fatal rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G035

21 January 2018

Identifiers

10.1345/APH.1G035

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16160000

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46701148&oldid=2127354404"